VIROPRO INC FILES (8-K) Disclosing Entry into a Material Definitive Agreement, Change in Directors or Principal Officers
(Edgar Glimpses Via Acquire Media NewsEdge) Item 1.01 Enty into a material definitive agreement
Viropro and Vivo Bio Tech Limited signed a non-binding Letter of Intent dated
August 21, 2013 effective for 180 days, subject to due diligence and contract
signing. The key terms of the Letter of Intent are as follows:
1. Viropro to appoint two (2) nominees of Vivo Bio Tech Ltd, as Directors on
2. Vivo Bio Tech to assist in raising loans for Viropro or Alpha Biologics or
any new or suitable corporate structure up to fifteen million dollars U.S.
($15,000,000 USD) to initiate production at the mammalian production plant of
Alpha Biologics with appropriate and necessary validations.
3. Vivo Bio Tech will assist Alpha Biologics in providing scientists
for product development, manufacturing and engineering and in general, to
operate the mammalian production facility.
4. The proposed terms of the transaction with Vivo Bio Tech are subject, among
other things, to Due Diligence and approval by both parties' respective Boards
of Directors and shareholders.
Item 5.02 Departure of directors and certain officers
On September 15, 2013, Deborah O'Shea, General Counsel and Chief Operating
Officer (COO) of Viropro, resigned.
[ Back To Technology News's Homepage ]